Research location
Palma de Mallorca
Balearic Islands, Spain
Advertisement
Research activity in Palma de Mallorca
Balearic Islands, SpainCureCurrent currently publishes aggregate city-level research activity for this location: 170 trials and 192 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Palma de Mallorca
170 linked trials · page 1 of 4Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)NCT07179380 · 2026-01-07 · 1 site observation
RECRUITING
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerNCT06793215 · 2025-10-24 · 1 site observation
RECRUITING
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical PracticeNCT07284121 · 2025-07-15 · 1 site observation
RECRUITING
Efficacy of Remote Monitoring of Patients With Heart Failure and Reduced Ejection Fraction by Using Caaring® SoftwareNCT06920160 · 2025-04-15 · 1 site observation
RECRUITING
Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.NCT06724159 · 2024-12-13 · 2 site observations
RECRUITING
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint InhibitorNCT06472245 · 2024-12-03 · 1 site observation
RECRUITING
Bronchial Blockers vs Double-Lumen Tubes in Obese PatientsNCT07031986 · 2024-08-15 · 1 site observation
RECRUITING
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)NCT05920356 · 2023-11-16 · 1 site observation
RECRUITING
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)NCT05489705 · 2022-08-16 · 1 site observation
RECRUITING
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)NCT07218029 · 2021-05-12 · 1 site observation
RECRUITING
Personalised Behavioural Intervention in Cancer Screening ProgrammesNCT07722442 · 2026-10-01 · 1 site observation
NOT_YET_RECRUITING
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor ResectionNCT07128199 · 2025-12-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Implementation of a Diabetic Foot Prevention Strategy in Primary Care (iMplanta Study)NCT07004179 · 2025-09-01 · 1 site observation
NOT_YET_RECRUITING
Effectiveness, Implementation and Spillover Effects of a Culturally Adapted DPP in Spanish Primary Care CentersNCT06871059 · 2025-09-01 · 1 site observation
NOT_YET_RECRUITING
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPDNCT06981078 · 2025-07-02 · 1 site observation
ACTIVE_NOT_RECRUITING
Empowering Healthy Lifestyle Personalised Intervention to Prevent and Control Obesity: The HealthyW8 ProjectNCT07011368 · 2025-07-01 · 1 site observation
NOT_YET_RECRUITING
Observational Study on the Patient's Ability to Use a Digital Platform in Heart FailureNCT06869408 · 2025-02-24 · 1 site observation
COMPLETED
Influence of Social Determinants on Lifestyle Modification Adherence in People With PrediabetesNCT06488677 · 2024-06-30 · 1 site observation
UNKNOWN
Peer-led Intervention for Individuals With Major Depression.NCT06398561 · 2024-05-10 · 1 site observation
COMPLETED
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)NCT05853575 · 2024-02-01 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Impact of Liquid Biopsy in Participants With a Clinical Diagnosis of Advanced CancerNCT05846594 · 2023-09-14 · 1 site observation
COMPLETED
An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast CancerNCT05592483 · 2023-07-07 · 1 site observation
TERMINATED
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)NCT05878769 · 2023-06-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Triple vs High Dose Inhaled CORticosteroidsNCT05919394 · 2023-06-01 · 1 site observation
WITHDRAWN
A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung CancerNCT05775289 · 2023-03-15 · 1 site observation
COMPLETED
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseNCT05595642 · 2022-12-29 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung DiseaseNCT05176951 · 2022-12-22 · 1 site observation
COMPLETED
Phase IV, a Clinical Trial to Assess Safety and Convenience of the Change From DTG/3TC to BIC/FTC/TAF in People With HIV, Good Virological Control and Neuropsychiatric VulnerabilitiesNCT05549180 · 2022-10-06 · 1 site observation
COMPLETED
Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung CancerNCT05403385 · 2022-08-26 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial HypertensionNCT05147805 · 2022-08-24 · 1 site observation
COMPLETED
Digital App and Platform for Supporting Medicines Control and Optimization in Older Individuals With Heart FailureNCT05353803 · 2022-07-01 · 1 site observation
COMPLETED
Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast CancerNCT05296746 · 2022-05-03 · 1 site observation
ACTIVE_NOT_RECRUITING
Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic SubtypeNCT05207709 · 2022-03-28 · 1 site observation
TERMINATED
Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13)NCT04811092 · 2022-03-18 · 1 site observation
TERMINATED
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast CancerNCT05132582 · 2022-03-07 · 1 site observation
ACTIVE_NOT_RECRUITING
mHealth Intervention to Prevent Type 2 Diabetes Mellitus (Phase II Study)NCT05110625 · 2021-12-01 · 1 site observation
COMPLETED
mHealth Intervention to Support Diabetes Medication AdherenceNCT05006872 · 2021-10-06 · 1 site observation
COMPLETED
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)NCT04961996 · 2021-08-27 · 2 site observations
ACTIVE_NOT_RECRUITING
Observational Analysis of Palbociclib Treatment in Patients With First Line Therapy for Locally Advanced and/or Metastatic Breast CancerNCT04874025 · 2021-07-31 · 1 site observation
COMPLETED
Effectiveness of a Nurse-led Personalized Telephone Intervention on Lifestyle Changes in Diabetes Prevention.NCT04735640 · 2021-04-13 · 1 site observation
COMPLETED
mHealth Intervention to Support Diabetes Medication Adherence (Pilot Study)NCT04738591 · 2020-12-30 · 1 site observation
COMPLETED
A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study.NCT04742413 · 2020-12-29 · 2 site observations
TERMINATED
A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung CancerNCT04619797 · 2020-12-15 · 1 site observation
COMPLETED
RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)NCT04597125 · 2020-11-09 · 1 site observation
ACTIVE_NOT_RECRUITING
Precision Lifestyle Intervention and Anthropometric, Nutritional, and Metabolic Health OutcomesNCT07450066 · 2020-10-27 · 1 site observation
COMPLETED
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPCNCT04446117 · 2020-10-19 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeNCT04464564 · 2020-09-11 · 1 site observation
TERMINATED
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)NCT04513925 · 2020-08-24 · 1 site observation
COMPLETED
Spanish Real World Data on Patients Treated With Durvalumab After Chemoradiotherapy.NCT04285866 · 2020-05-21 · 1 site observation
COMPLETED
Clinical Utility of Liquid Biopsy in Brigatinib ALK+ PatientsNCT04223596 · 2020-05-04 · 1 site observation
ACTIVE_NOT_RECRUITING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.